Actemra – First FDA Approved Drug for Giant Cell Arteritis
Genentech announced on May 22 that…
rheumnow.com
Ustekinumab inhibits Th1 and Th17 polarisation in a patient with giant cell arteritis
Although glucocorticoids (GC) remain the corner stone of giant cell arteritis (GCA) treatment, GC-sparing…
ard.bmj.com